Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA repair and recombination protein RAD54B (RAD54B) is an ATP-dependent DNA helicase belonging to the SWI2/SNF2 and DEAD-like helicase superfamilies, essential for homologous recombination and double-strand DNA break repair in human cells[1][3][4]. RAD54B interacts with RAD51 and DMC1, promoting and stabilizing DNA strand pairing during recombination and cell division[1][4]. The gene is highly expressed in testis and spleen, suggesting critical roles in meiotic and mitotic recombination. RAD54B functions as an accessory factor in DNA repair, enabling genomic stability, and its loss or mutation is linked to several cancer types, including colorectal and breast cancer[4]. While not commonly targeted by approved drugs, RAD54B is considered a potential therapeutic target for interventions seeking to modulate DNA repair pathways in cancer therapy and other diseases characterized by genomic instability[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA repair and recombination protein RAD54B (RAD54B).